Conmed's Expanding Surgical Product Offerings Help Boost Stock 18% In May
This article was originally published in The Gray Sheet
FDA marketing approval for Linvatec's Endopearl tissue connector for fixation of soft tissue grafts in the femoral socket during anterior cruciate ligament reconstruction, announced May 13, gave parent Conmed's stock a leg up in May.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.